Inactive Instrument

Genetron Holdings Limited

Equities

GTH

US37186H2094

Biotechnology & Medical Research

Genetron Holdings Limited Provides Revenue Guidance for Year 2021

March 25, 2021 at 10:47 am

Genetron Holdings Limited provided revenue guidance for the year 2021. For the period, the company expects revenue to be around RMB 615 million to RMB 625 million, representing around 45%-47% growth over 2020.

Latest news about Genetron Holdings Limited

Genetron Holdings Limited(NasdaqGM:GTH) dropped from NASDAQ Composite Index	03-28	CI
New Genetron Holding Limited completed the acquisition of Genetron Holdings Limited	03-27	CI
ADRs End Lower; Saverone 2014 Ltd. Declines 17.7%	12/10/23	DJ
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	12/10/23	MT
Sector Update: Health Care	12/10/23	MT
North American Morning Briefing : Hopes A Mild Inflation Print Will Keep Fed on Hold	12/10/23	DJ
Genetron Holdings Signs Merger Agreement to Go Private; Shares Soar Premarket	12/10/23	MT
Genetron Holdings Signs Merger Agreement to Go Private	11/10/23	MT
New Genetron Holding Limited agreed to acquire Genetron Holdings Limited for $130 million.	10/10/23	CI
Genetron Gets Nasdaq Notification Regarding Minimum Bid Price Requirement	23/05/23	MT
Genetron Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	12/05/23	CI
American Depositary Receipts of Asian Stocks Lower Amid Banking Sector Worries	27/03/23	MT
Genetron Holdings Regains Compliance With Nasdaq's Listing Rule	18/01/23	MT
Earlier US Stock Market Losses Weighed on Asian Equities	28/12/22	MT
Genetron Holdings Receives Non-Compliance Notice from Nasdaq	07/11/22	MT
Earnings Flash (GTH) GENETRON HOLDINGS LIMITED Reports Q2 Loss $-0.38	12/10/22	MT
Genetron Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/10/22	CI
Asian ADRs Decline in Monday Trading	26/09/22	MT
Genetron Holdings Limited(NasdaqGM:GTH) dropped from S&P Global BMI Index	19/09/22	CI
Sector Update: Health Care Stocks Decline Premarket Monday	22/08/22	MT
Genetron Gets Non-Binding Takeover Offer from CEO	22/08/22	MT
Sizhen Wang made a non binding proposal to acquire the remaining 49.2% stake in Genetron Holdings Limited from Genetron Health (Hong Kong) Company Limited and others for $60 million.	21/08/22	CI
Genetron Holdings Limited Provides Revenue Guidance for the Year 2022	02/06/22	CI
Transcript : Genetron Holdings Limited, Q1 2022 Earnings Call, Jun 02, 2022	02/06/22
Earnings Flash (GTH) GENETRON HOLDINGS LIMITED Posts Q1 Revenue $17.40M	02/06/22	MT

Chart Genetron Holdings Limited

Duration

Period

More charts

Company Profile

Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within the China market.

Sector

Biotechnology & Medical Research

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+52.36%	56.69B
IQVIA HOLDINGS INC.	-3.86%	41B
LONZA GROUP AG	+38.14%	38.11B
CELLTRION, INC.	-12.01%	26.89B
ICON PUBLIC LIMITED COMPANY	+14.13%	25.59B
ALNYLAM PHARMACEUTICALS, INC.	-21.62%	18.59B
BIO-TECHNE CORPORATION	+0.21%	12.39B
MEDPACE HOLDINGS, INC.	+25.96%	11.99B
UNITED THERAPEUTICS CORPORATION	+23.02%	11.88B

Other Biotechnology & Medical Research